Laurie Stelzer - Jun 1, 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
CFO
Signature
/s/ Elizabeth Gelfand , Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 05:56 PM
Previous filing
May 16, 2022
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +57.8K $0.00 57.8K Jun 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRTX Employee Stock Option (Right to Buy) Award $0 +91.2K $0.00 91.2K Jun 1, 2022 Common Stock 91.2K $39.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a Restricted Stock Unit grant with a vesting period of 4 years that vests 25% annually from grant date.
F2 25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.